In recent years, there has been an increasing focus on the role of LAMs in various types of leukemia, including acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML) (9, 41–44). This evidence concerns the gene LAMB2 and B-cell chronic lymphocytic leukemia.